News

A German-American team of IT security researchers has investigated how users choose the PIN for their mobile phones and how they can be convinced to use a more secure number combination. They also showed that the blacklist used by Apple to prevent particularly frequent PINs could be optimised and that it would make even greater sense to implement one on Android devices.

A dolutegravir-containing regimen exhibited a superior safety profile in a large, NIH-supported study of pregnant women.

Can cancer cells' ability to rapidly change their genetic mass be used as a weapon against malignant tumors? Researchers at Uppsala University have produced a substance that has shown promising results in both animal experiments and in human cancer cells.

Researchers from the University of Bristol are pioneering the use of virtual reality or "VR" as a tool to design the next generation of therapeutics.

Researchers at the University of Virginia School of Medicine have discovered why obesity causes high blood pressure and identified potential ways of treating that form of high blood pressure.

Pairing chemotherapy nanodrugs with a nutritional supplement can reduce devastating side effects while decreasing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan’s National Health Research Institutes.

Researchers have discovered a mechanism that could lead to new immunotherapies for patients with head and neck cancers.

Researchers at ETH Zurich and Bern University Hospital have developed a method for predicting circulatory failure in patients in intensive care units – enabling clinicians to intervene at an early stage. Their approach uses machine learning methods to evaluate an extensive body of patient data.

Scientists at Osaka University built a new computing device from field-programmable gate arrays (FPGA) that can be customized by the user for maximum efficiency in artificial intelligence applications.

A novel drug-delivery technology that uses a harmless virus to deliver an antibody gene into human cells can lead to sustained antibody production; this strategy could be applied to other infectious diseases.